Fachbeirat des Instituts

Um die hohe Qualität der wissenschaftlichen Forschung zu gewährleisten, werden alle Institute der Max-Planck-Gesellschaft regelmäßig von unabhängigen Fachbeiräten begutachtet. Deren Mitglieder sind Experten von weltweit führenden Forschungseinrichtungen und Universitäten. Der Max-Planck-Präsident ernennt die Mitglieder auf der Basis von Vorschlägen des Instituts. Sie werden für eine Amtszeit von maximal sechs Jahren berufen.

Unser Fachbeirat umfasst die folgenden 24 Mitglieder:

• Prof. Dr. Julie Ahringer, 
  Wellcome Trust/Cancer Research UK Gurdon Institute, Cambridge, UK
• Prof. Dr. Peer Bork,
  Structural and Computational Biology, EMBL Heidelberg, Germany
• Prof. Dr. Cynthia J. Burrows,
  Department of Chemistry, The University of Utah, USA
• Prof. Dr. David W. Chandler,
  Sandia National Laboratories, California, USA
• Prof. Dr. Graeme Davis,
  Department of Biochemistry and Biophysics, University of California, San Francisco, USA
• Prof. Dr. Thomas W. Ebbesen,
  ISIS, Laboratoire des Nanostructures, Strasbourg Cedex, France
• Prof. Dr. Witold Filipowicz,
  Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland
• Prof. Dr. Lucio Frydman
  Department of Chemical and Biological Physics, Weizmann Institute of Science, Rehovot, Israel
• Prof. Dr. Yukiko Goda, 
  Laboratory for Synaptic Plasticity and Connectivity, RIKEN Brain Science Institute, Saitama, Japan
• Prof. Dr. Astrid Gräslund,
  Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden
• Prof. Dr. Angela Gronenborn,
  Department of Structural Biology, University of Pittsburgh, Pittsburgh, USA
• Prof. Dr. Rebecca W. Heald,
  Department of Molecular & Cell Biology, University of California, Berkeley, USA
• Prof. Dr. Johan Hofkens,
  Molecular Imaging and Photonics, KU Leuven, Leuven, Belgium
• Prof. Dr. Laurinda Jaffe,
  School of Medicine, University of Connecticut, Farmington, USA
• Prof. Dr. Ute Kaiser,
  Electron Microscopy Group of Materials Science, Universität Ulm, Germany
• Prof. Dr. Kinneret Keren,
  Physics Department, Technion – Israel Institute of Technology, Haifa, Israel
• Prof. Dr. Iain Mattaj, (CHAIR)
  Fondazione Human Technopole, Milano, Italy
• Prof. Dr. Ann McDermott,
  Department of Chemistry, Columbia University, New York, USA
• Prof. Dr. Jane Mellor,
  Deparment of Biochemistry, University of Oxford, Oxford, UK
• Prof. Dr. Daniel M. Neumark,
  College of Chemistry, University of California, Berkeley, USA
• Prof. Dr. Anna Marie Pyle,
  Biological & Biomedical Sciences, Yale University, New Haven, USA
• Prof. Dr. José Rizo-Rey,
  Department of Biophysics, Medical Center, University of Texas Southwestern Medical Center, Dallas, USA
• Prof. Dr. Randy Schekman,
  Department of Molecular and Cell Biology, University of California, Berkeley, USA
• Prof. Dr. Thomas U. Schwartz,
  Department of Biology, Massachussetts Institute of Technology, Cambridge, USA
• Prof. Dr. Jeremy C. Smith, 
  Oak Ridge National Laboratory, Oak Ridge, USA
• Prof. Dr. Beth Stevens,
  Boston Children’s Hospital, Harvard Medical School, Boston, USA
• Prof. Dr. Peter Tielemann,
  Biochemistry Biocomputing Group, University of Calgary, Calgary, Canada
• Prof. Dr. Joachim Wittbrodt,
  Centre for Organismal Studies, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany